PT1040106E - Derivados de cromano substituidos com carboxi uteis como agonistas de adrenoreceptor beta 3 - Google Patents

Derivados de cromano substituidos com carboxi uteis como agonistas de adrenoreceptor beta 3

Info

Publication number
PT1040106E
PT1040106E PT98963240T PT98963240T PT1040106E PT 1040106 E PT1040106 E PT 1040106E PT 98963240 T PT98963240 T PT 98963240T PT 98963240 T PT98963240 T PT 98963240T PT 1040106 E PT1040106 E PT 1040106E
Authority
PT
Portugal
Prior art keywords
uteis
carboxy
chroman derivatives
derivatives substituted
adrenoreceptor agonists
Prior art date
Application number
PT98963240T
Other languages
English (en)
Inventor
Richard D Connell
Timothy G Lease
Jeremy Baryza
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PT1040106E publication Critical patent/PT1040106E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98963240T 1997-12-19 1998-12-16 Derivados de cromano substituidos com carboxi uteis como agonistas de adrenoreceptor beta 3 PT1040106E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99462097A 1997-12-19 1997-12-19

Publications (1)

Publication Number Publication Date
PT1040106E true PT1040106E (pt) 2002-11-29

Family

ID=25540853

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98963240T PT1040106E (pt) 1997-12-19 1998-12-16 Derivados de cromano substituidos com carboxi uteis como agonistas de adrenoreceptor beta 3

Country Status (24)

Country Link
EP (1) EP1040106B1 (pt)
JP (1) JP2001526282A (pt)
KR (1) KR20010033188A (pt)
CN (1) CN1284952A (pt)
AT (1) ATE222901T1 (pt)
AU (1) AU749097B2 (pt)
BG (1) BG104593A (pt)
BR (1) BR9814302A (pt)
CA (1) CA2316971A1 (pt)
DE (1) DE69807523T2 (pt)
DK (1) DK1040106T3 (pt)
ES (1) ES2183434T3 (pt)
HU (1) HUP0004565A3 (pt)
ID (1) ID26524A (pt)
IL (1) IL136689A0 (pt)
NO (1) NO20003083L (pt)
NZ (1) NZ505200A (pt)
PL (1) PL341229A1 (pt)
PT (1) PT1040106E (pt)
RU (1) RU2223269C2 (pt)
SK (1) SK9362000A3 (pt)
TR (1) TR200001927T2 (pt)
UA (1) UA62993C2 (pt)
WO (1) WO1999032476A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035605A1 (es) 2000-12-11 2004-06-16 Bayer Corp Derivados de aminometil cromano di-sustituidos, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos utiles como agonistas beta-3-adreno-receptores
AR035858A1 (es) * 2001-04-23 2004-07-21 Bayer Corp Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3
US20040265991A1 (en) * 2001-10-17 2004-12-30 Naoaki Taoka Process for preparation of (s)-alpha-halomethylpyridine-methanol derivatives
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
US7560575B2 (en) 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
RU2392277C2 (ru) * 2005-12-28 2010-06-20 Асино Фарма Аг Способ получения рацемического небиволола
ES2534336B1 (es) * 2013-10-18 2016-01-28 Artax Biopharma Inc. Derivados de cromeno como inhibidores de la interacción TCR-Nck
ES2534318B1 (es) * 2013-10-18 2016-01-28 Artax Biopharma Inc. Derivados de cromeno sustituidos por alcóxido como inhibidores de la interacción TCR-Nck

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
RU2032684C1 (ru) * 1991-04-08 1995-04-10 Джон Вайс энд Бразер Лимитед Способ получения производных 4-оксохинолина или хромона или их фармацевтически приемлемых солей
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
BR9406823A (pt) * 1993-06-14 1996-03-26 Pfizer Aminas secundárias e agentes anti-diabéticos e antiobesidade
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
EP0801060A1 (en) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists

Also Published As

Publication number Publication date
UA62993C2 (en) 2004-01-15
ATE222901T1 (de) 2002-09-15
AU1830099A (en) 1999-07-12
PL341229A1 (en) 2001-03-26
NO20003083D0 (no) 2000-06-15
EP1040106B1 (en) 2002-08-28
NO20003083L (no) 2000-08-15
IL136689A0 (en) 2001-06-14
EP1040106A1 (en) 2000-10-04
DE69807523T2 (de) 2003-01-09
KR20010033188A (ko) 2001-04-25
DE69807523D1 (de) 2002-10-02
WO1999032476A1 (en) 1999-07-01
BR9814302A (pt) 2000-10-10
ID26524A (id) 2001-01-11
SK9362000A3 (en) 2001-09-11
BG104593A (en) 2001-09-28
JP2001526282A (ja) 2001-12-18
DK1040106T3 (da) 2002-12-02
HUP0004565A2 (hu) 2001-08-28
ES2183434T3 (es) 2003-03-16
AU749097B2 (en) 2002-06-20
RU2223269C2 (ru) 2004-02-10
TR200001927T2 (tr) 2001-06-21
NZ505200A (en) 2002-09-27
CA2316971A1 (en) 1999-07-01
HUP0004565A3 (en) 2002-12-28
CN1284952A (zh) 2001-02-21

Similar Documents

Publication Publication Date Title
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
EP1017713A4 (en) CYCLIC AGONISTS AND ANTAGONISTS OF THE C5A RECEPTORS AND G-PROTEIN COUPLED RECEPTORS
AR005987A1 (es) Terapia combinada para la osteoporosis
BG104247A (bg) Производни на резорцинола
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
PT1054887E (pt) Derivados biciclicos de piridina e pirimidina como antagonistas de receptores no neuropeptido y
BR9711805A (pt) Compostos e métodos para providenciar preparações farmacologicamente ativas e uso dos mesmos
CY1107493T1 (el) Μεθοδοι και συνθεσεις για την προληψη ανεκτικοτητας στα βρογχοδιασταλτικα
PT934325E (pt) Trisanidridos biciclicos de tetrafosfonato
PT951282E (pt) Prevenção e tratamento de doenças esqueléticas com agonistas e2 de protaglandinas selectivos do subtipo de receptores ep2
AU2962295A (en) Cannabinoid receptor antagonists
DE69635026D1 (de) Varianten des menschlichen wachstumshormons
DK1955700T3 (da) Terapeutisk behandling af androgenreceptor-betingede lidelser
EP1007556A4 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
PT1040106E (pt) Derivados de cromano substituidos com carboxi uteis como agonistas de adrenoreceptor beta 3
EP0786995A4 (pt)
AP9801269A0 (en) Prostaglandin agonists.
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
ATE389023T1 (de) Kontrolle der schotendehiszenz
PT1144365E (pt) Inibidores da adesao de celulas mediada por alfa4beta1
ES2156642T3 (es) Composicion que comprende un derivado de acido cinamico y un polimero poliaminado.
WO2002048134A3 (en) Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
SV2002000041A (es) Derivados de resorcinol ref. pc10529/82897/bb
SE9801494D0 (sv) Novel use
AR006616A1 (es) Derivados carboxilicos utiles como inhibidores de los receptores de las endotelinas y composiciones farmaceuticas que los contienen